222 Users Online
Pancreatic and Bile Duct Stone Management Market by Product (ERCP Catheters, Guidewire, Sphincterotome, Dilation Balloon Catheters and Biliary Stents)
Worldwide revenue from the Pancreatic and Bile Duct Stone Management Market stands at US$ 1.29 Billion in 2023, with the global market estimated to surge ahead at a CAGR of 4.4% to reach a valuation of US$ 1.99 Billion by the end of 2033.
Pancreatic and Bile duct stone management Market Size (2023)
US$ 1.29 Billion
Projected Market Value (2033)
US$ 1.99 Billion
Global Market Growth Rate (2023 to 2033)
Market Share of Top 5 Countries
As analysed by Persistence Market Research, Sphincterotome segment held the market share of about 20.3% in 2022. Overall, Pancreatic and Bile duct stone management market sales account for around 0.40% revenue share in the global catheters, stents & guidewire market, which was valued at around US$ 66.29 Billion at the end of 2023.
The Global market for Pancreatic and Bile Duct Stone Management recorded a historic CAGR of 3.8% in the last 8 years from 2014 to 2022.
Gallstones are a term that refers to both bile duct and pancreatic stones. They are tiny, pebble-like items formed by hardened pancreatic or gallbladder fluids. Gallstones that persist in the gallbladder may not be harmful; however, biliary stones form when a gallstone moves to the bile duct and becomes stuck.
It can form anywhere in the bile duct where there is bile, such as the liver, pancreas, and common bile duct, and it can lead to infection and other serious complications. Pancreatic stones are typically composed of calcium carbonate fragments that have crystallised due to digestive enzymes and become lodged in the duct connecting the pancreas to the small intestine.
Inflammation, severe infection, and serious organ damage are all possible symptoms of Pancreatic and Bile duct stones. Gallstones of both types are usually treatable with advanced endoscopic techniques such as ERCP (Endoscopic retrograde cholangiopancreatography). The increase in R&D activity for the launch of novel medications and therapies has been brought on by the growing consumer awareness of early stones diagnosis.
The global market is thus likely to show high growth over the coming years at a CAGR of 4.4% and reach a global market size of US$ 1.99 Billion by 2033.
“Increasing Awareness for Gastrointestinal Conditions and Early Diagnosis”
The growing population of emerging markets are becoming more aware of the stone management problems, so, there is a chance that advanced stone management products will become more popular. This is due to increased access to better healthcare services and facilities.
The rising public awareness, increased incidence of gastrointestinal disorders in emerging markets such as China, India, Africa, and others is anticipated to receive timely diagnosis and treatment.
“Research & Development Advancements Leading to Effective Clinical Use”
The global market for innovative devices for the management of bile duct and pancreatic stones is expected to grow as material science advances and manufacturing funding for clinical studies increases. This scientifically based new product market introduction is predicted to promote product usage in Endoscopic retrograde cholangiopancreatography operations.
“Increasing Adoption of ERCP (Endoscopic retrograde cholangiopancreatography) in Advanced Treatment Protocols”
ERCP techniques that uses a combination of luminal endoscopy and fluoroscopic imaging to diagnose and treat conditions associated with the pancreatobiliary system. There is increased knowledge of the equipment used in ERCP to treat problems. The market for managing pancreatic and common bile duct stones will develop as more government funding for R&D and numerous studies into the safer use and improved efficiency of these devices are conducted.
According to a study published in the journal of Endoscopy International Open on trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP), there was a 37% increase in therapeutic ERCPs.
According to the European Society of Gastrointestinal Endoscopy (ESGE), the ERCP issued standard guidelines for the treatment protocol for common bile duct and pancreatic stone management.
“Adoption of the Minimally-Invasive Treatment for Pancreatic and Bile Duct Stones”
Open surgery was previously available, but with the introduction of endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic cholecystectomy (LC), the minimally invasive approach has nearly replaced laparotomy due to its well-known advantages. These benefits has boosted the usage of ERCP as a first-line treatment for pancreatic and common bile duct stone management.
“Unfavourable Reimbursement Policies”
Undesirable reimbursement instances in several regions are impeding the growth of technological innovations such as hepatocellular and biliary stents. The new technologies related to hepatocellular and biliary stents are expected to face additional challenges in obtaining reimbursement, which may slow down healthcare providers' preference for these stents.
“Lack of ERCP Skilled Assessment Guideline”
ERCP is a complex endoscopic procedure that necessitates extensive experience and training to conduct the procedure effectively and safely. The absence of standardised guidelines for qualifying endoscopists to practice ERCP is predicted to increase ERCP complications, stifling market growth. It is the riskiest procedure that gastrointestinal endoscopists regularly perform, with mortality and morbidity rates of 5-10% and 0.1-1%, respectively.
“Post ERCP Complications and their Side Effects”
Complications can occur in one to five percent of cases, depending on the surgeon's skill and the underlying disease. The most frequent cause is pancreatitis, which is caused by pancreatic irritation caused by the dye used to take a picture and can take place even with highly experienced physicians.
Why is the United States Market Booming?
“Growing Advanced Policies”
The United States accounted for around 94.9% market share in the global Pancreatic and Bile duct stone management market in 2022.
Annual stones incidence in the United States have been significantly rising, and this trend is anticipated to continue for the next ten years. The country's enormous potential for healthcare spending makes it a very profitable market for Pancreatic and Bile duct stone management.
Favourable government initiatives and policies with reimbursement scenarios are also enhancing the capability of various market participants to manufacture novel drugs. All of these elements create an advantageous environment for stone management.
Why is the Germany Market Booming in Europe?
“Growing Advanced Surgical Procedures & Changing Lifestyle”
The Germany accounted for around 16.5% market share in Europe Pancreatic and Bile duct stone management market in 2022.
The growing popularity of minimally invasive and non-invasive surgical procedures continues to be a major trend in the Pancreatic and Bile duct stone management market. The increasing incidence of Pancreatic and Bile stones along with the availability of affordable, minimally invasive treatments is likely to sustain the demand for catheters, stents & lithotripsy.
Genetic, lifestyle and diet are some of the major factors behind the growth of the Pancreatic and Bile duct stone management market. Dietary factors such as excessive sodium intake and consumption of sodium-rich junk food contribute to the formation of bile stones. Lifestyle factors, such as the increasingly sedentary nature and work environment of today's urban workers, have also contributed to the rise in stones.
What does India contribute to the market for Stone Management?
“New Suppliers with Quality Generic Products”
With a 2.9% market share, India held market share the global market in 2022.
The ERCP catheters, Sphincterotome, stents and related devices, as well as advancements in implementation techniques, have expanded treatment options for pancreatic and biliary diseases.
The rising incidence of gastrointestinal conditions in India is expected to provide a substantial growth possibility for minimally invasive techniques. Furthermore, the low cost of pancreatic and bile duct stone management devices such as self-expanding balloons and metal stents is expected to drive the pancreatic and biliary stone management market. The market will benefit from the introduction of alternative treatments for ERCP, sphincterotomy, stents, and lithotripsy, which have been linked to an increased prevalence of pancreatitis and other complications.
Which product type of the market for Pancreatic and Bile duct stone management will contribute the most?
“Increasing Demand for Sphincterotome”
The global Pancreatic and Bile duct stone management is divided into catheters, stents & lithotripsy based on the kind of product type. The market for Sphincterotome which accounts for 20.3% of the market in 2022.
The Sphincterotome product in Pancreatic and Bile duct stone management segment will grow during the forecast period due to rising demand with less side effects and are becoming more and more popular than that of ERCP catheters.
Due to their improved safety, low side effects, and great treatment efficacy, patients are diverting towards sphincterotome treatment rather than ERCP catheters.
A significant success rate in sphincterotome with supporting treatments, and technological approvals for lithotripsy are further key factors supporting the growth of this product.
Which Indication Has Dominated the Pancreatic and Bile Duct Stone Management Market Globally?
The global Pancreatic and Bile duct stone management is divided into pancreatic stones & bile duct stones based on the kind of indication. The market for bile duct stones which is expected to account for 76.7% of the market.
The frequency of occurrence increases as a person ages. Being overweight increases the likelihood of developing bile duct stones, especially in women, because the bile excretion of cholesterol increases. On the other hand, patients with drastic weight loss or on an empty stomach are more likely to develop gallstones due to biliary stasis. In addition, there is also a hormonal association with gallstones.
Which End User Has Dominated the Pancreatic and Bile Duct Stone Management Market Globally?
“Wide availability, easy access of Pancreatic and Bile duct stone management”
Hospitals held a market share of around 46.2% in 2022.
Global market expansion is anticipated to be fuelled by the rapid improvement of healthcare hospitals access in developing nations like China, India, and numerous Latin American nations as a result of rising healthcare spending and successful implementation of health programmes like stone management.
Over the forecast period, the technological advanced treatments & new stents have anticipated to grow with high CAGR. This can be linked to increased consumer preference for getting early diagnosis from pancreatic or bile duct stone management with numerous techniques has boosted the growth in the Pancreatic and Bile duct management. The management of stones by skilled professionals using ERCP catheters, Sphincterotome, biliary stents & lithotripsy & with less recovery time in hospitals have increased demand.
Mergers and acquisitions, product launches have become one of the main growth tactics used by market players, taking into account competitive efforts in the global market. A number of well-known companies are expanding their product lines through acquisitions and engaging with both established and developing markets.
Key instances include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the Pancreatic and Bile duct stone management market, which are available in the full report
2023 to 2033
Historical Data Available for
2014 to 2022
USD Million for Value
Key Countries Covered
Key Market Segments Covered
Key Companies’ Profile
Customization & Pricing
Available upon Request
The global market is currently valued at around US$ 1.29 Billion in 2023.
The global market estimates for 2023 is US$ 1.29 Billion.
The global market is set to reach a valuation of US$ 1.99 Billion by the end of 2033.
Sales of the market are set to witness growth at a CAGR of 4.4% between 2023 and 2033.
Demand for the market increased at a 3.8% CAGR from 2014 to 2022.
U.S., Italy, U.K., France and Germany accounted for the dominant share in the global market as of year 2022, holding around 65.1% market share.
The U.S. accounts for around 94.8% share of the North American market in 2022.
Japan held a market share of about 42.7% of the East Asia Pancreatic and Bile duct stone management market in 2022.
Germany held about 4.7% of the global market share at the end of 2022.
India held about 2.9% of the global market share at the end of 2022.